Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
250
-
Total 13F shares, excl. options
-
181M
-
Shares change
-
+6.65M
-
Total reported value, excl. options
-
$2.02B
-
Value change
-
+$85.8M
-
Put/Call ratio
-
0.04
-
Number of buys
-
145
-
Number of sells
-
-98
-
Price
-
$11.18
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q2 2024
273 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q2 2024.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 250 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 181M shares
of 237M outstanding shares and own 76.37% of the company stock.
Largest 10 shareholders include BlackRock Inc. (18.6M shares), VANGUARD GROUP INC (14.5M shares), Invesco Ltd. (13.2M shares), Nuveen Asset Management, LLC (8.93M shares), STATE STREET CORP (8.06M shares), D. E. Shaw & Co., Inc. (6.82M shares), AMERICAN CENTURY COMPANIES INC (6.05M shares), GEODE CAPITAL MANAGEMENT, LLC (5.24M shares), AWM Investment Company, Inc. (5.1M shares), and TWO SIGMA ADVISERS, LP (4.65M shares).
This table shows the top 250 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.